by Lisa DeScenza | Oct 22, 2020 | Home News (Right), News, News-2020
News & Events News TriSalus Life Sciences Appoints Trevor McCaw as Chief Commercial Officer Experienced commercial leader solidifies Company’s management team as it integrates novel therapies with innovative drug delivery DENVER and CHICAGO, October 22, 2020 –...
by Lisa DeScenza | Sep 29, 2020 | News, News-2020
News & Events News TriSalus Life Sciences Appoints Steven Katz, M.D., Chief Medical Officer Renowned surgeon, clinician, and researcher to advance work to combine novel immuno-oncology therapies with regional drug delivery to improve outcomes in metastatic liver...
by Lisa DeScenza | Sep 22, 2020 | News, News-2020
News & Events News TriSalus Life Sciences Lays Out Therapeutic Strategy Upon Acquisition of First Therapeutic Candidate Initiating clinical trials to evaluate investigational toll-like receptor 9 agonist, SD-101, in patients with uveal melanoma liver metastases...
by Michael Persons | Aug 3, 2020 | News, News-2020
News & Events News TriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9...
by Michael Persons | Jun 1, 2020 | News, News-2020
News & Events News TriSalus Appoints Rajesh B. Mistry Chief Financial Officer June 1, 2020–TriSalus Life Sciences (“TriSalus”), a company committed to transforming outcomes for patients with solid tumors, today announced the appointment of Rajesh B. Mistry as Chief...
by Michael Persons | Jan 13, 2020 | News, News-2020
News & Events News TriSalus Life Sciences Launches the New TriNav™ Infusion System, an Innovative Solution Designed to Overcome Infusion Barriers Within Solid Tumors January 13, 2020–TriSalus™ Life Sciences (“TriSalus”), a company committed to transforming...
Recent Comments